基层眼科诊疗中未诊断的年龄相关性黄斑变性患病率
该横断面研究纳入美国阿拉巴马州伯明翰基层眼科诊所的644名60岁及以上、病历记载黄斑健康者,共1288眼,经彩色眼底照相和盲法分级发现320眼(24.8%)存在未诊断的年龄相关性黄斑变性(AMD)。未诊断AMD与患者年龄较大、男性及受教育程度低于高中相关,眼科医生与验光师的未诊断率无显著差异。
要点
- 病历记载黄斑健康的眼中,24.8%(320/1288)经眼底照相发现存在未诊断的AMD。
- 未诊断AMD与年龄较大(OR 1.06)、男性(年龄校正OR 1.39)及受教育程度低于高中(年龄校正OR 2.40)相关。
- 眼科医生与验光师诊断未诊断AMD的患病率无显著差异(年龄校正OR 0.99)。
核心结论
- 约25.0%经基层眼科医生散瞳眼底检查判定为正常的眼,经眼底照相和受训评级者判定存在提示AMD的黄斑特征。
- 30.0%未诊断AMD的眼具有大玻璃膜疣,若被诊断则可用营养补充剂治疗。
- 随着未来几年更有效的早期AMD治疗策略出现,基层眼科可能需要改进AMD检测策略。
研究设计与样本
- 横断面研究,纳入美国阿拉巴马州伯明翰基层眼科诊所的644名60岁及以上、病历记载黄斑健康者,共1288眼,由31名基层眼科医生或验光师诊治。
- 入组时间为2009年5月1日至2011年12月31日,数据分析时间为2016年5月1日至2016年12月20日。
- AMD定义依据临床年龄相关性黄斑病变分期系统,基于彩色眼底照相和盲法分级者判定。
主要发现
- 968眼(75.2%)无AMD,与病历一致;320眼(24.8%)存在AMD,尽管病历中无AMD诊断。
- 未诊断AMD眼中,32眼(10.0%)有色素沉着,43眼(13.4%)有色素减退,249眼(77.8%)有小玻璃膜疣,250眼(78.1%)有 intermediate 玻璃膜疣,96眼(30.0%)有大玻璃膜疣。
- 未诊断AMD与患者年龄较大相关(OR 1.06;95%CI 1.04-1.09;P < .001)。
- 未诊断AMD与男性相关(年龄校正OR 1.39;95%CI 1.02-1.91;P = .04)。
- 未诊断AMD与受教育程度低于高中相关(年龄校正OR 2.40;95%CI 1.03-5.62;P = .04)。
关键数值与推荐
- AMD依据临床年龄相关性黄斑病变分期系统定义,基于彩色眼底照相和盲法分级者判定。
- 未诊断AMD定义为病历中无AMD诊断但眼底照相显示AMD。
- 样本特征:644名参与者中男性231名(35.9%)、女性413名(64.1%);平均(SD)年龄69.4(6.1)岁;白人611名(94.9%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Age-related macular degeneration (AMD) is the leading cause of irreversible vision impairment in older adults in the United States, yet little is known about whether AMD is appropriately diagnosed in primary eye care. OBJECTIVES: To examine the prevalence of eyes with AMD in patients seen in primary eye care clinics who purportedly have normal macular health per their medical record and the association of AMD with patient and physician characteristics. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study of primary eye care practices in Birmingham, Alabama, 644 persons 60 years or older with normal macular health per medical record based on their most recent dilated comprehensive eye examination by a primary eye care ophthalmologist or optometrist were enrolled from May 1, 2009, through December 31, 2011. Data analysis was performed from May 1, 2016, through December 20, 2016. MAIN OUTCOMES AND MEASURES: Presence of AMD as defined by the Clinical Age-Related Maculopathy Staging system based on color fundus photography and a masked grader. Types of AMD-associated lesions were noted. Patient health and physician characteristics were collected. RESULTS: The sample consisted of 1288 eyes from 644 participants (231 [35.9%] male and 413 [64.1%] female; mean [SD] age, 69.4 [6.1] years; 611 white [94.9%]) seen by 31 primary eye care ophthalmologists or optometrists. A total of 968 eyes (75.2%) had no AMD, in agreement with their medical record; 320 (24.8%) had AMD despite no diagnosis of AMD in the medical record. Among eyes with undiagnosed AMD, 32 (10.0%) had hyperpigmentation, 43 (13.4%) had hypopigmentation, 249 (77.8%) had small drusen, 250 (78.1%) had intermediate drusen, and 96 (30.0%) had large drusen. Undiagnosed AMD was associated with older patient age (odds ratio [OR], 1.06; 95% CI, 1.04-1.09; P < .001), male sex (age-adjusted OR, 1.39; 95% CI, 1.02-1.91; P = .04), and less than a high school education (age-adjusted OR, 2.40; 95% CI, 1.03-5.62; P = .04). Prevalence of undiagnosed AMD was not different for ophthalmologists and optometrists (age adjusted OR, 0.99; 95% CI, 0.71-1.36; P = .94). CONCLUSIONS AND RELEVANCE: Approximately 25.0% of eyes deemed to be normal based on dilated eye examination by primary eye care physicians had macular characteristics that indicated AMD revealed by fundus photography and trained raters. A total of 30.0% of eyes with undiagnosed AMD had AMD with large drusen that would have been treatable with nutritional supplements had it been diagnosed. Improved AMD detection strategies may be needed in primary eye care as more effective treatment strategies for early AMD become available in the coming years.
引用
- Neely DC, Bray KJ, Huisingh CE, et al. Prevalence of Undiagnosed Age-Related Macular Degeneration in Primary Eye Care. JAMA Ophthalmol. 2017. PMID: 28448669. doi:10.1001/jamaophthalmol.2017.0830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。